Wave Life Sciences Ltd. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD from Q3 2014 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
Wave Life Sciences Ltd. quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from Q3 2014 to Q2 2024.
- Wave Life Sciences Ltd. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was -$32.9M, a 56% decline year-over-year.
- Wave Life Sciences Ltd. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending June 30, 2024 was -$74.2M, a 43.2% increase year-over-year.
- Wave Life Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$58.2M, a 63.9% increase from 2022.
- Wave Life Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$161M, a 31.6% decline from 2021.
- Wave Life Sciences Ltd. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was -$122M, a 18.8% increase from 2020.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Growth (%)